These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 32810579
41. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions. Li B, Harich K, Wegiel L, Taylor LS, Edgar KJ. Carbohydr Polym; 2013 Feb 15; 92(2):1443-50. PubMed ID: 23399175 [Abstract] [Full Text] [Related]
42. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations. Xie T, Taylor LS. Pharm Res; 2016 Mar 15; 33(3):739-50. PubMed ID: 26563205 [Abstract] [Full Text] [Related]
43. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization. Hörmann TR, Jäger N, Funke A, Mürb RK, Khinast JG, Paudel A. Int J Pharm; 2018 Dec 20; 553(1-2):408-421. PubMed ID: 30326284 [Abstract] [Full Text] [Related]
45. Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole. Monschke M, Kayser K, Wagner KG. AAPS PharmSciTech; 2021 Jan 12; 22(1):44. PubMed ID: 33438107 [Abstract] [Full Text] [Related]
52. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions. Figueirêdo CBM, Nadvorny D, Vieira ACQM, Schver GCRM, Soares Sobrinho JL, Rolim Neto PJ, Lee PI, Soares MFR. Eur J Pharm Sci; 2018 Jul 01; 119():208-218. PubMed ID: 29679707 [Abstract] [Full Text] [Related]
53. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole. Zhang S, Lee TWY, Chow AHL. Int J Pharm; 2019 Jan 30; 555():394-403. PubMed ID: 30513399 [Abstract] [Full Text] [Related]
54. Microstructure Formation for Improved Dissolution Performance of Lopinavir Amorphous Solid Dispersions. Li N, Taylor LS. Mol Pharm; 2019 Apr 01; 16(4):1751-1765. PubMed ID: 30811205 [Abstract] [Full Text] [Related]
56. Interplay of Drug-Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions. Bapat P, Paul S, Tseng YC, Taylor LS. Mol Pharm; 2024 Mar 04; 21(3):1466-1478. PubMed ID: 38346390 [Abstract] [Full Text] [Related]
57. Miniaturized Measurement of Drug-Polymer Interactions via Viscosity Increase for Polymer Selection in Amorphous Solid Dispersions. Auch C, Harms M, Golitsyn Y, Reichert D, Mäder K. Mol Pharm; 2019 May 06; 16(5):2214-2225. PubMed ID: 30920843 [Abstract] [Full Text] [Related]
58. Investigating the Correlation between Miscibility and Physical Stability of Amorphous Solid Dispersions Using Fluorescence-Based Techniques. Tian B, Tang X, Taylor LS. Mol Pharm; 2016 Nov 07; 13(11):3988-4000. PubMed ID: 27700109 [Abstract] [Full Text] [Related]
59. Co-release of paclitaxel and encequidar from amorphous solid dispersions increase oral paclitaxel bioavailability in rats. Petersen EF, Larsen BS, Nielsen RB, Pijpers I, Versweyveld D, Holm R, Tho I, Snoeys J, Nielsen CU. Int J Pharm; 2024 Apr 10; 654():123965. PubMed ID: 38442796 [Abstract] [Full Text] [Related]